230 related articles for article (PubMed ID: 3035025)
41. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
Engel AG; Lambert EH; Howard FM
Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
[TBL] [Abstract][Full Text] [Related]
42. Suppression of antibody responses to the acetylcholine receptor by natural antibodies.
Sundblad A; Hauser S; Holmberg D; Cazenave PA; Coutinho A
Eur J Immunol; 1989 Aug; 19(8):1425-30. PubMed ID: 2776827
[TBL] [Abstract][Full Text] [Related]
43. Correlating extent of neuromuscular instability with acetylcholine receptor antibodies.
Farrugia ME; Jacob S; Sarrigiannis PG; Kennett RP
Muscle Nerve; 2009 Apr; 39(4):489-93. PubMed ID: 19260064
[TBL] [Abstract][Full Text] [Related]
44. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
45. Antigen-specific therapy of experimental myasthenia gravis with acetylcholine receptor-gelonin conjugates in vivo.
Urbatsch IL; Sterz RK; Peper K; Trommer WE
Eur J Immunol; 1993 Mar; 23(3):776-9. PubMed ID: 8449224
[TBL] [Abstract][Full Text] [Related]
46. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia.
Vincent A
J Recept Res; 1987; 7(1-4):599-616. PubMed ID: 2442386
[TBL] [Abstract][Full Text] [Related]
47. Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
Bever CT; Dretchen KL; Blake GJ; Chang HW; Penn AS; Asofsky R
Ann Neurol; 1984 Jul; 16(1):9-13. PubMed ID: 6431900
[TBL] [Abstract][Full Text] [Related]
48. The pathophysiology of penicillamine-induced myasthenia gravis.
Kuncl RW; Pestronk A; Drachman DB; Rechthand E
Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
[TBL] [Abstract][Full Text] [Related]
49. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.
Engel AG; Uchitel OD; Walls TJ; Nagel A; Harper CM; Bodensteiner J
Ann Neurol; 1993 Jul; 34(1):38-47. PubMed ID: 7685992
[TBL] [Abstract][Full Text] [Related]
50. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
Berman PW; Heinemann SF
J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
[TBL] [Abstract][Full Text] [Related]
51. Neonatal experimental autoimmune myasthenia gravis.
Sanders DB; Cobb EE; Winfield JB
Muscle Nerve; 1978; 1(2):146-50. PubMed ID: 571528
[TBL] [Abstract][Full Text] [Related]
52. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
53. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice.
Jermy A; Beeson D; Vincent A
Eur J Immunol; 1993 Apr; 23(4):973-6. PubMed ID: 8458383
[TBL] [Abstract][Full Text] [Related]
54. [Effect of acetylcholine receptor antibody derived from myasthenia gravis on the rat central neuronal nicotinic acetylcholine receptor].
Li Z; Ju G; Qiu X
Zhonghua Nei Ke Za Zhi; 1997; 36(1):15-7. PubMed ID: 9812554
[TBL] [Abstract][Full Text] [Related]
55. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
[TBL] [Abstract][Full Text] [Related]
56. Myasthenia gravis: passive transfer to mice of antibody to human and mouse acetylcholine receptor.
Oda K; Korenaga S; Ito Y
Neurology; 1981 Mar; 31(3):282-7. PubMed ID: 6259556
[TBL] [Abstract][Full Text] [Related]
57. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.
Gomez CM; Wollmann RL; Richman DP
Acta Neuropathol; 1984; 63(2):131-43. PubMed ID: 6610275
[TBL] [Abstract][Full Text] [Related]
58. Human monoclonal immunoglobulins that bind the human acetylcholine receptor.
Eng H; Lefvert AK; Mellstedt H; Osterborg A
Eur J Immunol; 1987 Dec; 17(12):1867-9. PubMed ID: 3691628
[TBL] [Abstract][Full Text] [Related]
59. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
[TBL] [Abstract][Full Text] [Related]
60. How myasthenia gravis alters the safety factor for neuromuscular transmission.
Ruff RL; Lennon VA
J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
